BioNTech SE ADR (NASDAQ: BNTX) is -18.10% lower on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $90.29 in the last trading session, with the day’s gains setting it 3.03%.
Currently trading at $93.32, the stock is -5.25% and -15.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.25 million and changing 3.36% at the moment leaves the stock -10.87% off its SMA200. BNTX registered 0.21% gain for a year compared to 6-month loss of -21.43%. The firm has a 50-day simple moving average (SMA 50) of $109.9245 and a 200-day simple moving average (SMA200) of $104.69913.
The stock witnessed a -14.89% gain in the last 1 month and extending the period to 3 months gives it a -17.11%, and is -2.69% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.83% over the week and 4.21% over the month.
BioNTech SE ADR (BNTX) has around 6772 employees, a market worth around $22.39B and $2.98B in sales. Profit margin for the company is -24.07%. Distance from 52-week low is 21.94% and -29.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.53%).
with sales reaching $159.6M over the same period.The EPS is expected to shrink by -71.27% this year, but quarterly earnings will post -22.77% year-over-year. Quarterly sales are estimated to shrink -14.92% in year-over-year returns.
491.0 institutions hold shares in BioNTech SE ADR (BNTX), with institutional investors hold 59.66% of the company’s shares. The shares outstanding are 239.97M, and float is at 236.22M with Short Float at 1.36%. Institutions hold 21.94% of the Float.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4425 of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8216 and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2174 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
Still, SEC filings show that on Feb 20 ’25, Poetting Sierk (Officer) Proposed Sale 120,000 shares at an average price of $119.58 for $14.35 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
